Literature DB >> 4956777

Detoxification and immunogenic properties of endotoxin-containing precipitate of Brucella abortus.

F F Badakhsh, J W Foster.   

Abstract

Badakhsh, Fred F. (University of Georgia, Athens), and John W. Foster. Detoxification and immunogenic properties of endotoxin-containing precipitate of Brucella abortus. J. Bacteriol. 91:494-498. 1966.-Endotoxin-containing precipitates (ECP) were prepared from Brucella abortus strain 19A by aqueous ether extraction followed by ethyl alcohol precipitation. Lysozyme was the most effective of several enzymes tried for detoxification of endotoxin present in the precipitate. Trypsin was shown to reduce mouse lethal toxicity but not rabbit dermal toxicity. Immunological studies of ECP and enzyme-treated ECP demonstrated that lysozyme did not harm the immunogenic property of ECP, whereas heat, ribonuclease, lipase, and proteolytic enzymes had an adverse effect. Serological reactivity of ECP was increased after lysozyme treatment, whereas ribonuclease reduced serological activity.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4956777      PMCID: PMC314886          DOI: 10.1128/jb.91.2.494-498.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  Studies on an immunogenic agent against Brucella abortus. I. Preliminary studies of an immunologically active soluble agglutinogen.

Authors:  R C ALLEN
Journal:  Am J Vet Res       Date:  1961-05       Impact factor: 1.156

2.  THE EFFECT OF ENZYME TREATMENTS ON BRUCELLA ABORTUS CELL WALLS.

Authors:  R A BOBO; J W FOSTER
Journal:  J Gen Microbiol       Date:  1964-01

3.  Detoxification of endotoxin by splenic extracts.

Authors:  E E SMITH; S H RUTENBURG; A M RUTENBURG; J FINE
Journal:  Proc Soc Exp Biol Med       Date:  1963-07

4.  Immunological role of Brucella abortus cell walls.

Authors:  J W FOSTER; E RIBI
Journal:  J Bacteriol       Date:  1962-08       Impact factor: 3.490

5.  Immunizing properties of insoluble cell material derived from Brucella.

Authors:  J MARKENSON; D SULITZEANU; A L OLITZKI
Journal:  Nature       Date:  1959-06-13       Impact factor: 49.962

6.  Studies on the antigenic structure of Brucella suis with the aid of the agar gel precipitation technique. I. The resistance of antigens to physical, chemical and enzymatic treatments.

Authors:  A L OLITZKI; D SULITZEANU
Journal:  Br J Exp Pathol       Date:  1958-06

7.  Differentiation of smooth and nonsmooth colonies of Brucellae.

Authors:  P G WHITE; J B WILSON
Journal:  J Bacteriol       Date:  1951-02       Impact factor: 3.490

8.  The cultivation of brucellae on chemically defined media.

Authors:  L J RODE; G OGLESBY; V T SCHUHARDT
Journal:  J Bacteriol       Date:  1950-11       Impact factor: 3.490

9.  Studies on thermostable antigens extracted from Bacterium tularense and from tissues of animals dead of tularemia.

Authors:  C L LARSON
Journal:  J Immunol       Date:  1951-02       Impact factor: 5.422

10.  Physicochemical changes in endotoxin associated with loss of biological potency.

Authors:  E RIBI; W T HASKINS; K C MILNER; R L ANACKER; D B RITTER; G GOODE; R J TRAPANI; M LANDY
Journal:  J Bacteriol       Date:  1962-10       Impact factor: 3.490

View more
  3 in total

1.  Enzyme-linked immunosorbent assay with major outer membrane proteins of Brucella melitensis to measure immune response to Brucella species.

Authors:  S B Hunter; W F Bibb; C N Shih; A F Kaufmann; J R Mitchell; R M McKinney
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

2.  Preparation of a nontoxic and immunogenic polysaccharide fraction from a Haemophilus influenzae phenol-water extract.

Authors:  D Raichvarg; C Brossard; J Agneray
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

3.  Fractionation of Phenol Extracts from Brucella suis: Separation of Multiple Biologically Active Components.

Authors:  J R McGhee; B A Freeman
Journal:  Infect Immun       Date:  1970-09       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.